Long-term effects of benidipine on the regression of left ventricular hypertrophy in essential hypertension

Hideo Izawa, M. Yokota, T. Sobue, H. Inagaki, M. Koide, M. Maeda, F. Saito, T. Miyahara

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The effects of the calcium antagonist benidipine on left ventricular (LV) mass and the plasma level of endothelin (ET)-1 like immunoreactivity were analyzed in patients with essential hypertension. Twenty-six untreated essential hypertensive patients with LV hypertrophy and 9 untreated essential hypertensive patients without LV hypertrophy were given benidipine for 12 months. LV mass was calculated based on M-mode echocardiographic measurements. Benidipine reduced systolic and diastolic pressures from 173±12/101±10 to 140±10/85±10 mmHg, respectively, (p<0.01) without associated increase in heart rate in patients with LV hypertrophy. Benidipine also reduced the LV mass index in patients with LV hypertrophy (171±55 to 152±37 g/m2, p<0.01), but no change was noted in LV mass index in patients without hypertrophy. Changes in the LV mass index did not correlate with changes in systolic pressure. The plasma level of ET-1 like immunoreactivity was not affected by benidipine in patients with and without LV hypertrophy. This study provides new information concerning the long-term effects of benidipine; benidipine was used effectively as monotherapy for hypertension for 12 months and it reduced the LV mass in patients with hypertrophy.

Original languageEnglish
Pages (from-to)583-588
Number of pages6
JournalJapanese Journal of Clinical Pharmacology and Therapeutics
Volume27
Issue number3
DOIs
Publication statusPublished - 01-01-1996

Fingerprint

Left Ventricular Hypertrophy
Endothelin-1
Blood Pressure
Hypertrophy
Essential Hypertension
benidipine
Heart Rate
Hypertension
Calcium

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Izawa, Hideo ; Yokota, M. ; Sobue, T. ; Inagaki, H. ; Koide, M. ; Maeda, M. ; Saito, F. ; Miyahara, T. / Long-term effects of benidipine on the regression of left ventricular hypertrophy in essential hypertension. In: Japanese Journal of Clinical Pharmacology and Therapeutics. 1996 ; Vol. 27, No. 3. pp. 583-588.
@article{761d02668a6e442093c4931fd072e6ef,
title = "Long-term effects of benidipine on the regression of left ventricular hypertrophy in essential hypertension",
abstract = "The effects of the calcium antagonist benidipine on left ventricular (LV) mass and the plasma level of endothelin (ET)-1 like immunoreactivity were analyzed in patients with essential hypertension. Twenty-six untreated essential hypertensive patients with LV hypertrophy and 9 untreated essential hypertensive patients without LV hypertrophy were given benidipine for 12 months. LV mass was calculated based on M-mode echocardiographic measurements. Benidipine reduced systolic and diastolic pressures from 173±12/101±10 to 140±10/85±10 mmHg, respectively, (p<0.01) without associated increase in heart rate in patients with LV hypertrophy. Benidipine also reduced the LV mass index in patients with LV hypertrophy (171±55 to 152±37 g/m2, p<0.01), but no change was noted in LV mass index in patients without hypertrophy. Changes in the LV mass index did not correlate with changes in systolic pressure. The plasma level of ET-1 like immunoreactivity was not affected by benidipine in patients with and without LV hypertrophy. This study provides new information concerning the long-term effects of benidipine; benidipine was used effectively as monotherapy for hypertension for 12 months and it reduced the LV mass in patients with hypertrophy.",
author = "Hideo Izawa and M. Yokota and T. Sobue and H. Inagaki and M. Koide and M. Maeda and F. Saito and T. Miyahara",
year = "1996",
month = "1",
day = "1",
doi = "10.3999/jscpt.27.583",
language = "English",
volume = "27",
pages = "583--588",
journal = "Japanese Journal of Clinical Pharmacology and Therapeutics",
issn = "0388-1601",
publisher = "Japanese Society of Clinical Pharmacology and Therapeutics",
number = "3",

}

Long-term effects of benidipine on the regression of left ventricular hypertrophy in essential hypertension. / Izawa, Hideo; Yokota, M.; Sobue, T.; Inagaki, H.; Koide, M.; Maeda, M.; Saito, F.; Miyahara, T.

In: Japanese Journal of Clinical Pharmacology and Therapeutics, Vol. 27, No. 3, 01.01.1996, p. 583-588.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Long-term effects of benidipine on the regression of left ventricular hypertrophy in essential hypertension

AU - Izawa, Hideo

AU - Yokota, M.

AU - Sobue, T.

AU - Inagaki, H.

AU - Koide, M.

AU - Maeda, M.

AU - Saito, F.

AU - Miyahara, T.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - The effects of the calcium antagonist benidipine on left ventricular (LV) mass and the plasma level of endothelin (ET)-1 like immunoreactivity were analyzed in patients with essential hypertension. Twenty-six untreated essential hypertensive patients with LV hypertrophy and 9 untreated essential hypertensive patients without LV hypertrophy were given benidipine for 12 months. LV mass was calculated based on M-mode echocardiographic measurements. Benidipine reduced systolic and diastolic pressures from 173±12/101±10 to 140±10/85±10 mmHg, respectively, (p<0.01) without associated increase in heart rate in patients with LV hypertrophy. Benidipine also reduced the LV mass index in patients with LV hypertrophy (171±55 to 152±37 g/m2, p<0.01), but no change was noted in LV mass index in patients without hypertrophy. Changes in the LV mass index did not correlate with changes in systolic pressure. The plasma level of ET-1 like immunoreactivity was not affected by benidipine in patients with and without LV hypertrophy. This study provides new information concerning the long-term effects of benidipine; benidipine was used effectively as monotherapy for hypertension for 12 months and it reduced the LV mass in patients with hypertrophy.

AB - The effects of the calcium antagonist benidipine on left ventricular (LV) mass and the plasma level of endothelin (ET)-1 like immunoreactivity were analyzed in patients with essential hypertension. Twenty-six untreated essential hypertensive patients with LV hypertrophy and 9 untreated essential hypertensive patients without LV hypertrophy were given benidipine for 12 months. LV mass was calculated based on M-mode echocardiographic measurements. Benidipine reduced systolic and diastolic pressures from 173±12/101±10 to 140±10/85±10 mmHg, respectively, (p<0.01) without associated increase in heart rate in patients with LV hypertrophy. Benidipine also reduced the LV mass index in patients with LV hypertrophy (171±55 to 152±37 g/m2, p<0.01), but no change was noted in LV mass index in patients without hypertrophy. Changes in the LV mass index did not correlate with changes in systolic pressure. The plasma level of ET-1 like immunoreactivity was not affected by benidipine in patients with and without LV hypertrophy. This study provides new information concerning the long-term effects of benidipine; benidipine was used effectively as monotherapy for hypertension for 12 months and it reduced the LV mass in patients with hypertrophy.

UR - http://www.scopus.com/inward/record.url?scp=0029906716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029906716&partnerID=8YFLogxK

U2 - 10.3999/jscpt.27.583

DO - 10.3999/jscpt.27.583

M3 - Article

AN - SCOPUS:0029906716

VL - 27

SP - 583

EP - 588

JO - Japanese Journal of Clinical Pharmacology and Therapeutics

JF - Japanese Journal of Clinical Pharmacology and Therapeutics

SN - 0388-1601

IS - 3

ER -